News and Announcements
Amber in 2019: More users, more funding more awards
- Published December 16, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Revenue Milestone $100k/annum.
- $400k round
- Finovate Dubai Winner
Amber is the fastest, safest way to buy bitcoin in Australia. Backed by the Queensland University of Technology, featured on AFR, and most recently the winner of the Finovate “Best of Show” awards in Dubai, Amber is on track to be one of Australia’s top performing companies in 2020.
After successfully closing another $400k in September, Amber has continued to grow and will cross $100k in annualised revenue by year’s end. Download Amber now & get in touch with the team for more information about Amber’s next funding round set to open in early 2020.
About Amber
Amber is a Bitcoin exchange, wallet & micro-investment app – all in the palm of your hand.
We’re leveraging the world’s fastest-growing and best-performing asset classes to deliver a mobile-first, automated investment platform for the retail market. We’ve chosen to begin with bitcoin because of its inherent asymmetries, open access, security guarantee & the fact that it’s digitally native.
An extremely scalable business model and product, that generates revenue from day one, and solves a problem for tens of millions of people around the world. Amber successfully closed a $1m seed round in 2018, via a transparent equity-based capital raise (no ICO), that including funding from QUT making us the first Bitcoin fintech with backing from a major Australian University.
We’ve built a product, released it to market and have a stable, growing user base – all run by a talented, professional team.
Amber is a rare opportunity to get exposure to this market by investing in the infrastructure, or “shovels” being built on and around the most exciting new asset in the world today.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
